Meralgia Paresthetica Clinical Trial
— METOfficial title:
The Effect of Muscle Energy Technique on Femoral Meralgia Paraesthesia in Postpartum: A Randomized Controlled Trial
Verified date | February 2021 |
Source | October 6 University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To investigate the effect of muscle energy technique on Femoral meralgia paraesthesia in a postpartum female. BACKGROUND: meralgia paraesthesia is one of the serious disorders in the postpartum female which results in pain and less physical activities. ………HYPOTHESES: This study hypothesized that: muscle energy technique will have a significant effect on Femoral meralgia paraesthesia in postpartum female
Status | Completed |
Enrollment | 30 |
Est. completion date | January 30, 2021 |
Est. primary completion date | December 30, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 25 Years to 40 Years |
Eligibility | Inclusion Criteria: - Thirty meralgia paraesthesia postpartum female Patients - with positive Pelvic compression test - age ranging from 25:40 years - post vaginal delivery or post-operative (postpartum) persistent dysthesia in anterolateral thigh (one side or both) - body mass index (20:29.9) Kg/m2 Exclusion Criteria: - difficulty to communicate or to understand program instructions - other conditions that caused pain (for example fibromyalgia and arthritis) - any psychiatric or cognitive symptoms any other musculoskeletal disorders or neurologic diseases of the lower extremities and spine |
Country | Name | City | State |
---|---|---|---|
Egypt | Lama S Mahmoud | Al Jizah | Select State |
Lead Sponsor | Collaborator |
---|---|
October 6 University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Femoral nerve conduction latency | Femoral nerve conduction latency measured via the Neuropack S1 MEB9004 EMG device | 4 weeks | |
Secondary | Pelvic compression test | the therapist applied a downward compression force to the pelvis and maintained a pressure for 45 seconds. If the patients reported an alleviation of symptoms the test is considered positive | four weeks | |
Secondary | Numeric Pain Rating Scale (NPRS) | it includes 11-point numeric scale ranges from no pain with score of "0" to worst pain imaginable with score of "10" | four weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06187883 -
Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve
|
||
Completed |
NCT02577510 -
Comparing Ways to Freeze the Nerve That Provides Thigh Sensation
|
Phase 3 | |
Withdrawn |
NCT04046406 -
Pelvic Pain Treated With MR-guided Cryoanalgesia
|
N/A | |
Recruiting |
NCT05893732 -
HILT for Meralgia Paresthetica: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT06251882 -
Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia
|
N/A | |
Completed |
NCT04004052 -
Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica
|
N/A | |
Completed |
NCT04499911 -
Efficacy of Neural Prolotherapy in Treatment of Meralgia Paresthetica
|
N/A |